Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows an expanded list of study locations and updated contact details. The core study design, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T01:26:31.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    - Updated notice about government funding lapse and current operating status with links to official sources. - Version bumped from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:30:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:19:54.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version updated to v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:44:54.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:23:15.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility locations across various countries, while also removing several previous location entries. Additionally, there are updates to the names of certain compounds and a revision number change.
    Difference
    7%
    Check dated 2025-08-30T12:10:30.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.